Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Waidmann

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 4, 2016
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosisFabian Finkelmeier, Özge Canli, Andrea Tal, et al.
Cancers|July 13, 2024
Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter TrialVera Himmelsbach, Matthias Jeschke, Christian M Lange, et al.
The Journal of Biological Chemistry|February 11, 2015
The E3 ubiquitin ligase parkin is recruited to the 26 S proteasome via the proteasomal ubiquitin receptor Rpn13Miguel A Aguileta, Jelena Korac, Thomas M Durcan, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinomaVerena Köberle, Bernd Kronenberger, Thomas Pleli, et al.
BMC Medicine|September 13, 2012
Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort studyBernd Kronenberger, Ina Rudloff, Malte Bachmann, et al.
Oncotarget|March 3, 2016
Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinomaGeorgios Grammatikos, Niklas Schoell, Nerea Ferreirós, et al.
Nature Communications|March 18, 2018
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cellsMonika Raab, Mourad Sanhaji, Yves Matthess, et al.
Pathogens (Basel, Switzerland)|January 21, 2023
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis BJanett Fischer, Shuang Long, Eleni Koukoulioti, et al.
Cancers|April 12, 2022
Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World AnalysisMartin S Schulz, Sebastian Wolf, Vera Struck, et al.
Future Oncology (London, England)|May 17, 2021
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerMarkus Moehler, Maurice Michel, Alexander Stein, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|April 4, 2016
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosisFabian Finkelmeier, Özge Canli, Andrea Tal, et al.
Cancers|July 13, 2024
Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter TrialVera Himmelsbach, Matthias Jeschke, Christian M Lange, et al.
The Journal of Biological Chemistry|February 11, 2015
The E3 ubiquitin ligase parkin is recruited to the 26 S proteasome via the proteasomal ubiquitin receptor Rpn13Miguel A Aguileta, Jelena Korac, Thomas M Durcan, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinomaVerena Köberle, Bernd Kronenberger, Thomas Pleli, et al.
BMC Medicine|September 13, 2012
Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort studyBernd Kronenberger, Ina Rudloff, Malte Bachmann, et al.
Oncotarget|March 3, 2016
Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinomaGeorgios Grammatikos, Niklas Schoell, Nerea Ferreirós, et al.
Nature Communications|March 18, 2018
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cellsMonika Raab, Mourad Sanhaji, Yves Matthess, et al.
Pathogens (Basel, Switzerland)|January 21, 2023
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis BJanett Fischer, Shuang Long, Eleni Koukoulioti, et al.
Cancers|April 12, 2022
Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World AnalysisMartin S Schulz, Sebastian Wolf, Vera Struck, et al.
Future Oncology (London, England)|May 17, 2021
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerMarkus Moehler, Maurice Michel, Alexander Stein, et al.
Pageof 12